News | Stroke | August 24, 2022

iHealthScreen Inc. Introduces An Automated Stroke Prediction Model, based on AI and Color Fundus Imaging

iHealthScreen is the First Company to Develop An AI- and Color-Fundus- Image-Based Stroke Prediction model, Funded by the National Institutes of Health (NIH) 

iHealthScreen is the First Company to Develop An AI- and Color-Fundus- Image-Based Stroke Prediction model, Funded by the National Institutes of Health (NIH) 


August 24, 2022 — iPredict late stroke prediction model provides a fully automated prediction score for incident stroke and identifies the individuals who are at risk of stroke within 5-years. These results were presented at the international conference: Society for Brain Mapping and Therapeutics World Congress and show that the prediction model may help prevent stroke, saving millions of people from death or disability. 

Once high-resolution images of the patient’s eyes have been captured using a color fundus camera and submitted to the iPredict AI System, the stroke prediction results are available in a fully automated report in less than 60 seconds. The entire test can easily and reliably be completed within 5 minutes. 

This prediction model offers an overall accuracy of 82.4% for identifying an individual at risk of having an incident stroke within 5-years. 

iPredict achieved higher accuracy than existing stroke prediction models such as Framingham and Chads scores (iPredict-stroke accuracy 82.4% compared to Framingham score 64.9%, and the CHADS2VASC score achieved 63.8% accuracy respectively on the same dataset). 

iPredict’s stroke model can be used to alert physicians of the need to take further preventive measures for these patients in the primary care setting. 

The company also has AI-based screening tools for early diagnosis of diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma which are CE certified and TGA/Australian health approved. 

For more information: https://www.iHealthScreen.org 


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now